Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
US-2026035482-A1 · Feb 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Faucette Ryan patents
Faucette Ryan is listed as an inventor on 40 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Faucette Ryan |
| Total patents | 40 |
| First publication | Dec 17, 2015 |
| Latest publication | Feb 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Cleaved high molecule weight kininogen (HMWK) antibodies and methods of using
US-12493047-B2 · Dec 9, 2025 · US
Assays for determining plasma kallikrein system biomarkers
US-12442824-B2 · Oct 14, 2025 · US
Tgf-beta inhibitors and use thereof
US-2025282857-A1 · Sep 11, 2025 · US
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
US-12384854-B2 · Aug 12, 2025 · US
Metabolite biomarkers for diseases associated with the contact activation system
US-2025199014-A1 · Jun 19, 2025 · US
Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk
US-2025172567-A1 · May 29, 2025 · US
Metabolite biomarkers for diseases associated with the contact activation system
US-12188948-B2 · Jan 7, 2025 · US
Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK
US-12135329-B2 · Nov 5, 2024 · US
Tgf-beta inhibitors and therapeutic use thereof
US-2024294623-A1 · Sep 5, 2024 · US
Recent patents
Latest publications not already listed above.
Rna biomarkers for hereditary angioedema
US-2024271211-A1 · Aug 15, 2024 · US
Protein biomarkers for diseases associated with the contact activation system
US-2024142468-A1 · May 2, 2024 · US
RNA biomarkers for hereditary angioedema
US-11884979-B2 · Jan 30, 2024 · US
Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) andcleaved hmwk
US-2023408528-A1 · Dec 21, 2023 · US
Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation
US-11826758-B2 · Nov 28, 2023 · US
Protein biomarkers for diseases associated with the contact activation system
US-11815516-B2 · Nov 14, 2023 · US
Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation
US-2023182139-A1 · Jun 15, 2023 · US
Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK
US-11668718-B2 · Jun 6, 2023 · US
Metabolite biomarkers for diseases associated with the contact activation system
US-2022365101-A1 · Nov 17, 2022 · US
Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation
US-11458477-B2 · Oct 4, 2022 · US
Assays for determining plasma kallikrein system biomarkers
US-2022291232-A1 · Sep 15, 2022 · US
Assays for determining plasma kallikrein system biomarkers
US-11372002-B2 · Jun 28, 2022 · US
Evaluation and treatment of bradykinin-mediated disorders
US-2022170936-A1 · Jun 2, 2022 · US
Metabolite biomarkers for diseases associated with the contact activation system
US-11340237-B2 · May 24, 2022 · US
Methods of determining levels of cleaved and/or intact kininogen
US-11156612-B2 · Oct 26, 2021 · US
Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation
US-2021322972-A1 · Oct 21, 2021 · US
Protein biomarkers for diseases associated with the contact activation system
US-2021285962-A1 · Sep 16, 2021 · US
Immunoassay to detect cleaved high molecular weight kininogen
US-2021270842-A1 · Sep 2, 2021 · US
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
US-11084884-B2 · Aug 10, 2021 · US
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
US-2021087293-A1 · Mar 25, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Takeda Pharmaceuticals Co | 25 |
| Dyax Corp | 14 |
| Scholar Rock Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/6893 | 25 |
| A61P7/10 | 24 |
| C07K16/40 | 21 |
| G01N2800/224 | 20 |
| G01N2800/50 | 18 |